.png)
.png)
Chief, Division of Infectious Diseases
Division of Infectious Diseases, Department of Medicine, Vagelos College of Physicians and Surgeons, New York-Presbyterian Columbia University Irving Medical Center, New York, NY, USA
Disclosure(s): Bill and Melinda Gates Foundation: Grant/Research Support; Gilead Sciences: Grant/Research Support; Janssen Global Services, LLC: Grant/Research Support; Merck: Grant/Research Support; National Institute of Allergy and Infectious Diseases (NIAID): Grant/Research Support; National Institutes of Health (NIH): Grant/Research Support; Sanofi Pasteur Inc.: Grant/Research Support
Dr. Magda Sobieszczyk is the Harold Neu Professor of Infectious Diseases (in Medicine) and Chief of Infectious Diseases at the Columbia University Irving Medical Center in New York. She received her degrees from Harvard and Columbia College of Physicians and Surgeons. Subsequently she completed her clinical training in internal medicine and infectious diseases at the Columbia University Irving Medical Center. Her research focuses on the development, testing, and implementation of biomedical interventions to prevent HIV infection and most recently COVID-19: specifically vaccines, monoclonal antibodies, and pre-exposure prophylaxis (PrEP). She is also the PI of the NIH-funded Columbia Collaborative Clinical Trials Unit which has been advancing the science of HIV and, most recently, of emerging infections like SARS-CoV-2. She has led many large-scale NIH-funded international studies in this area. Her work also extends to testing interventions that address healthcare disparities and access to COVID-19 and HIV care and prevention. Since the start of the COVID-19 pandemic, she has led and has been involved in cohort studies evaluating SARS-CoV-2 epidemiology, evolution of antibody responses, and clinical outcomes over time.